Clinical Trials on Chikungunya Virus Infection in Mexico

Total 1236 results

Hospital Reg. Lic. Adolfo Lopez Mateos
Instituto de Terapia Celular: ITC

Unknown

Mesenchymal Stem Cells in Patients Diagnosed With COVID-19

Covid19

Mexico
Instituto Nacional de Ciencias Medicas y Nutricion...

Completed

Peripheral Arterial Insufficiency Associated With HIV/AIDS (AIHIV)

Acquired Immunodeficiency Syndrome | HIV | Arterial Insufficiency

Mexico
National Institute of Cancerología
Instituto Nacional de Enfermedades Respiratorias

Completed

Impact of Valganciclovir on Severe IRIS-Kaposi Sarcoma Mortality: an Open-label, Parallel, Randomized Controlled-trial.

Kaposi Sarcoma | Human Immunodeficiency Virus | Immune Reconstitution Syndrome

Mexico
Hospital Reg. Lic. Adolfo Lopez Mateos

Unknown

Outpatient Treatment With CoVid-19 With Prexablu

Sars Cov 2

Mexico
Novavax
Instituto Mexicano del Seguro Social

Completed

Safety and Immunogenicity of an A (H1N1) 2009 Influenza Virus-like Particle (VLP) Vaccine

Seasonal Influenza

Mexico
GlaxoSmithKline

Completed

Assessment of Clinical Consistency of Three Production Lots of GSK Biologicals' HRV Vaccine

Infections, Rotavirus

Mexico, Colombia, Peru
National Institute of Respiratory Diseases, Mexico

Completed

Evaluation of a COVID-19 Rapid Diagnostic Test in ER Departments in Mexico: a Multi-center Study

Covid19

Mexico
GlaxoSmithKline

Completed

A Study in Adolescent Females to Explore Cytomegalovirus Infection

Infections, Cytomegalovirus

Finland, United States, Mexico
Centro Medico ABC

Terminated

Treatment of Severe and Critical COVID-19 Pneumonia With Convalescent Plasma

Covid-19

Mexico
Instituto Nacional de Ciencias Medicas y Nutricion...
Instituto Nacional de Medicina Genomica

Completed

Prospective Determination of COVID-19 Infection Rate in a Chemotherapy Unit in Mexico.

Cancer | Covid19 | Tumor

Mexico
Hospital General de Mexico

Completed

Association of the Neutrophil/Lymphocyte Ratio With Pulmonary Complications and Mortality in COVID-19 Patients

Covid19 | Pulmonary Complication

Mexico
Sanofi Pasteur, a Sanofi Company

Completed

Study of the DTaP-IPV-Hep B-PRP~T Combined Vaccine Following a Primary Series of DTacP IPV-HepB-PRP-T or Infanrix Hexa™

Hepatitis B | Pertussis | Tetanus | Diphtheria | Poliomyelitis | Haemophilus Influenzae Type B Infection

Mexico
National Institute of Respiratory Diseases, Mexico

Completed

Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial) (HYDRA)

Severe Acute Respiratory Syndrome | COVID-19

Mexico
Hospital Central Militar

Completed

Study on the Safety and Efficacy of Convalescent Plasma in Patients With Severe COVID-19 Disease (PC-COVID-HCM)

Severe COVID-19 Disease

Mexico
Hanmi Pharmaceutical Company Limited

Unknown

Safety,Tolerability and Pharmacokinetic Study of Recombinant Human Interferon Alfa 2B in Chronic Hepatitis C Patients (HM10660A)

Chronic Hepatitis C Virus Genotype I

Mexico
Hospital General de México Dr. Eduardo Liceaga
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran; CCINSHAE... and other collaborators

Terminated

Safety and Efficacy of Maraviroc and/or Favipiravir With Standard Therapy in Severe COVID-19 Adults (COMVIVIR)

COVID-19

Mexico
Instituto Nacional de Ciencias Medicas y Nutricion...
Hospital General Dr. Manuel Gea González; Instituto Nacional de Cardiologia... and other collaborators

Unknown

Safety and Efficacy of Convalescent Plasma Transfusion for Patients With COVID-19 (EPCOvid-1)

COVID-19

Mexico
National Institute of Respiratory Diseases, Mexico

Completed

Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial) (PHYDRA)

Severe Acute Respiratory Syndrome | COVID-19

Mexico
Unidad Temporal COVID-19 en Centro Citibanamex
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran; Instituto...

Completed

Antioxidants as Adjuvant Therapy to Standard Therapy in Patients With COVID-19 (ANTIOX-COVID)

Pneumonia, Viral | Covid19 | Oxidative Stress | ARDS

Mexico
Hospital General Ajusco Medio
Horacio Marquez-Gonzalez; Carlos Torruco-Sotelo; Sebastian Rodriguez-Llamazares

Completed

Risk Factors for Barotrauma in COVID-19

Covid19 | Barotrauma

Mexico
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of a Multi-Dose Quadrivalent Influenza Vaccine

Influenza

Mexico
Instituto Nacional de Ciencias Medicas y Nutricion...

Completed

Outcomes of Patients With COVID-19 in the Intensive Care Unit (MexCOVID-19)

Coronavirus Infections | COVID-19 | Viral Pneumonia Human Coronavirus

Mexico
Sanofi

Completed

A Phase 1b Trial to Evaluate Safety and Effect of SAR443122 on Immune System in Severe COVID-19

Corona Virus Infection

Mexico, Argentina, Brazil, Chile, Russian Federation
Sironax USA, Inc.

Completed

A Pilot Study to Assess Safety and Efficacy of SIR1-365 in Patients With Severe COVID-19

Corona Virus Infection

Pakistan, United States, Mexico
Instituto Nacional de Ciencias Medicas y Nutricion...

Suspended

Pyridostigmine as Immunomodulator in People Living With HIV

HIV-1-infection | Immune Deficiency | CD4+ T Lymphocytopenia | Immuno-senescence

Mexico
Instituto Nacional de Cardiologia Ignacio Chavez

Completed

Risk Factors and Computed Tomography Findings in COVID-19.

Pneumonia, Viral | Covid19 | ARDS | Computed Tomography

Mexico
Edda Sciutto Conde
Instituto Nacional de Cardiologia Ignacio Chavez; Hospital General de México... and other collaborators

Completed

Randomized Clinical Trial of Intranasal Dexamethasone as an Adjuvant in Patients With COVID-19

Covid19

Mexico
Guillermo Ceballos Reyes
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado

Recruiting

Effects of Cacao FLAvonoids in LOng Covid Patients (FLALOC) (FLALOC)

Fatigue Syndrome, Chronic | Long Covid19

Mexico
Escuela Militar de Graduados de Sanidad, SEDENA

Completed

Effect of Vitamin D Supplementation on Glutathione Peroxidase (GPx) Activity, Interleukin-6 (IL-6) Levels and Clinical Outcomes in Post-COVID-19 Patients (VITDPOSTCOVID)

Post-COVID19 Condition

Mexico
Coordinación de Investigación en Salud, Mexico
University College, London; Centro de Investigacion y Estudios Avanzados del... and other collaborators

Completed

Favipiravir +/- Nitazoxanide: Early Antivirals Combination Therapy in COVID-19 (FANTAZE)

Covid19

Mexico
Hospital Regional de Alta especialidad de Ixtapaluca
Hospital General de México Dr. Eduardo Liceaga

Completed

Association of the Neutrophil/Lymphocyte Ratio With Clinical Complications and Mortality in COVID-19 Patients

Covid-19

Mexico
Instituto Nacional de Ciencias Medicas y Nutricion...

Terminated

Use of Spironolactone for the Prevention of Electrolyte Abnormalities in Patients Treated With Amphotericin B

Patients With Fungic Infections

Mexico
Instituto Nacional de Rehabilitacion

Enrolling by invitation

Low-dose Hydroxychloroquine and Bromhexine: a Novel Regimen for COVID-19 Prophylaxis in Healthcare Professionals (ELEVATE)

Enzyme Inhibitors | Hydroxychloroquine | Antimalarials | Antirheumatic Agents

Mexico
University of Alberta

Withdrawn

Corticosteroids for COVID-19 (CORE-COVID)

Covid19

Colombia, Mexico
CMN "20 de Noviembre"

Unknown

Chloroquine Phosphate Prophylactic Use in Health Personnel Exposed to COVID-19 Patients

COVID-19

Mexico
CMN "20 de Noviembre"

Active, not recruiting

Estrogen Therapy in Non-severe COVID-19 Patients

Covid-19

Mexico
Instituto Nacional de Ciencias Medicas y Nutricion...

Recruiting

Continuous Glucose Monitorization in Hospitalized Patients With COVID-19

Diabetes Mellitus | Covid19

Mexico
National Institute of Allergy and Infectious Diseases...

Completed

VRC 705: A Zika Virus DNA Vaccine in Healthy Adults and Adolescents (DNA)

RNA Virus Infections | Virus Diseases | Flavivirus Infections | Flaviviridae Infections | Zika Virus Infection | Zika Virus | Flaviviral Diseases

United States, Puerto Rico, Mexico, Brazil, Colombia, Costa Rica, Ecuador, Panama, Peru
Laboratorios Silanes S.A. de C.V.

Completed

Metformin Glycinate, Treatment of Patients With COVID-19 and Severe Acute Respiratory Syndrome Secondary to SARS-CoV-2. (DMMETCOV19-2)

Severe Acute Respiratory Syndrome Coronavirus 2

Mexico
Coordinación de Investigación en Salud, Mexico
Ultra Laboratorios SA. de CV.

Recruiting

Hidroxicloroquina With Azitromicina Versus Hidroxicloroquina and Placebo Int Patients With Mild COVID-19 (Omehecatl)

Covid19

Mexico
ViiV Healthcare
GlaxoSmithKline

Completed

Study Of An Investigational Regimen Including FDA Approved HIV Drugs In HIV-Infected Pediatric Subjects

HIV Infections | Infection, Human Immunodeficiency Virus

United States, Portugal, Russian Federation, Mexico, Argentina, South Africa, Puerto Rico
GlaxoSmithKline

Completed

A Safety and Immune Study of 2 Types of GlaxoSmithKline's Varicella Vaccines Given as a 2-doses Course to Healthy Children 12-23 Months of Age.

Chickenpox | Chicken-pox Illness (Varicella Virus Disease)

Estonia, Thailand, Germany, Mexico, United Kingdom
Coordinación de Investigación en Salud, Mexico
Hospital Infantil de Mexico Federico Gomez

Completed

Efficacy of Vitamin D Supplementation to Prevent the Risk of Acquiring COVID-19 in Healthcare Workers (COVID-19)

Covid19 | Vitamin D

Mexico
Coordinación de Investigación en Salud, Mexico
Hospital General de México Dr. Eduardo Liceaga; Hospital Infantil de Mexico...

Completed

Efficacy of Vitamin D Treatment in Pediatric Patients Hospitalized by COVID-19 (COVID-19)

Covid19 | Children, Only | Vitamin D

Mexico
Instituto Nacional de Ciencias Medicas y Nutricion...

Unknown

Efficacy and Safety of a Highly Selective Semipermeable Membrane (AN-69 Oxiris) vs (Standard AN-69) in COVID-19 (oXAKI-COV)

Covid19 | AKI

Mexico
GlaxoSmithKline

Active, not recruiting

A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline's Herpes Zoster Subunit Vaccine (HZ/su) When Given on a Two-dose Schedule to Adults at Least 50 Years of Age (YOA) Who Had Prior Episode of Shingles

Herpes Zoster

Spain, Panama, Mexico, Russian Federation, Finland, Estonia, Hong Kong, United Kingdom
Enanta Pharmaceuticals, Inc

Terminated

Effects of EDP-938 in Hematopoietic Cell Transplant Recipients Who Are Infected With Acute Respiratory Syncytial Virus (RSV) of the Upper Respiratory Tract (RSVTx)

Respiratory Syncytial Virus Infections

Spain, Korea, Republic of, Israel, Canada, United States, Italy, France, Belgium, Brazil, Taiwan, Greece, Argentina, Mexico, South Africa, China, Poland, Colombia, Turkey, United Kingdom
National Institute of Medical Sciences and Nutrition...

Completed

COVID-19 Vaccine Hesitancy Among Rheumatic Diseases Patients

Covid19

Mexico
Grupo Mexicano para el Estudio de la Medicina Intensiva

Completed

In Situ Thrombolysis With tPA and Inflow Perfusion Analysis in Patient With Severe Covid-19 Infection

COVID-19

Mexico
Brown University
National Institute of Mental Health (NIMH); University of California, San Francisco and other collaborators

Completed

PrEP Seguro: Antiretroviral-based HIV Prevention Among Men at High Risk in Mexico

HIV Infections

Mexico

Clinical Trials on Chikungunya Virus Infection in Mexico

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Myanmar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations